25 XP   0   0   10

Ascentage Pharma Grp International
Buy, Hold or Sell?

Let's analyse Ascentage Pharma Grp International together

PenkeI guess you are interested in Ascentage Pharma Grp International. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ascentage Pharma Grp International. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ascentage Pharma Grp International

I send you an email if I find something interesting about Ascentage Pharma Grp International.

Quick analysis of Ascentage Pharma Grp International (30 sec.)










What can you expect buying and holding a share of Ascentage Pharma Grp International? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.26
Expected worth in 1 year
HK$-4.77
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
HK$-5.04
Return On Investment
-30.0%

For what price can you sell your share?

Current Price per Share
HK$16.80
Expected price per share
HK$11.16 - HK$20.75
How sure are you?
50%

1. Valuation of Ascentage Pharma Grp International (5 min.)




Live pricePrice per Share (EOD)

HK$16.80

Intrinsic Value Per Share

HK$-38.48 - HK$-21.81

Total Value Per Share

HK$-38.21 - HK$-21.54

2. Growth of Ascentage Pharma Grp International (5 min.)




Is Ascentage Pharma Grp International growing?

Current yearPrevious yearGrowGrow %
How rich?$9.7m$56.3m-$46.6m-478.6%

How much money is Ascentage Pharma Grp International making?

Current yearPrevious yearGrowGrow %
Making money-$127.7m-$121.8m-$5.8m-4.6%
Net Profit Margin-417.0%-421.0%--

How much money comes from the company's main activities?

3. Financial Health of Ascentage Pharma Grp International (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#679 / 1010

Most Revenue
#194 / 1010

Most Profit
#985 / 1010

Most Efficient
#717 / 1010

What can you expect buying and holding a share of Ascentage Pharma Grp International? (5 min.)

Welcome investor! Ascentage Pharma Grp International's management wants to use your money to grow the business. In return you get a share of Ascentage Pharma Grp International.

What can you expect buying and holding a share of Ascentage Pharma Grp International?

First you should know what it really means to hold a share of Ascentage Pharma Grp International. And how you can make/lose money.

Speculation

The Price per Share of Ascentage Pharma Grp International is HK$16.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ascentage Pharma Grp International.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ascentage Pharma Grp International, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.26. Based on the TTM, the Book Value Change Per Share is HK$-1.26 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-3.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ascentage Pharma Grp International.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.44-2.6%-0.44-2.6%-0.42-2.5%-0.45-2.7%-0.32-1.9%
Usd Book Value Change Per Share-0.16-1.0%-0.16-1.0%-0.39-2.3%0.100.6%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-1.0%-0.16-1.0%-0.39-2.3%0.100.6%0.000.0%
Usd Price Per Share3.48-3.48-3.28-3.82-2.39-
Price to Earnings Ratio-7.92--7.92--7.81--9.22--5.76-
Price-to-Total Gains Ratio-21.68--21.68--8.35--48.38--48.38-
Price to Book Ratio103.73-103.73-16.88-29.60-18.50-
Price-to-Total Gains Ratio-21.68--21.68--8.35--48.38--48.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.14368
Number of shares466
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.10
Usd Total Gains Per Share-0.160.10
Gains per Quarter (466 shares)-74.8947.96
Gains per Year (466 shares)-299.57191.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-300-3100192182
20-599-6100384374
30-899-9100575566
40-1198-12100767758
50-1498-15100959950
60-1797-1810011511142
70-2097-2110013431334
80-2397-2410015351526
90-2696-2710017261718
100-2996-3010019181910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.06.00.025.0%2.06.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.06.00.025.0%2.06.00.025.0%

Fundamentals of Ascentage Pharma Grp International

About Ascentage Pharma Grp International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation. It also has APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interaction for treating solid tumors and hematological malignancies; and APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection. In addition, it is involved in the development of APG-1252, a small molecule drug to restore apoptosis through selective inhibition of the Bcl-2 and Bcl-xL proteins for SCLC, lymphoma, and other solid tumors; APG-2449, an oral bioavailable inhibitor of FAK, ROS1, and ALK tyrosine kinases; APG-5918, an orally available and selective EED inhibitor; APG-265, a MDM2 protein degrade; and UBX1967/1325. In, addition it engages in medical research and development; venture capital investment; and rental services. The company has collaboration relationships with major biotechnology and pharmaceutical companies, and academic institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 17:30:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ascentage Pharma Grp International.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ascentage Pharma Grp International earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • A Net Profit Margin of -417.0% means that $-4.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ascentage Pharma Grp International:

  • The MRQ is -417.0%. The company is making a huge loss. -2
  • The TTM is -417.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-417.0%TTM-417.0%0.0%
TTM-417.0%YOY-421.0%+4.0%
TTM-417.0%5Y-3,857.3%+3,440.4%
5Y-3,857.3%10Y-3,454.9%-402.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-417.0%-200.1%-216.9%
TTM-417.0%-216.8%-200.2%
YOY-421.0%-288.3%-132.7%
5Y-3,857.3%-449.1%-3,408.2%
10Y-3,454.9%-605.5%-2,849.4%
1.1.2. Return on Assets

Shows how efficient Ascentage Pharma Grp International is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • -37.0% Return on Assets means that Ascentage Pharma Grp International generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ascentage Pharma Grp International:

  • The MRQ is -37.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.0%TTM-37.0%0.0%
TTM-37.0%YOY-31.2%-5.8%
TTM-37.0%5Y-51.4%+14.3%
5Y-51.4%10Y-40.4%-10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.0%-13.3%-23.7%
TTM-37.0%-12.8%-24.2%
YOY-31.2%-11.7%-19.5%
5Y-51.4%-13.9%-37.5%
10Y-40.4%-15.7%-24.7%
1.1.3. Return on Equity

Shows how efficient Ascentage Pharma Grp International is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • -1,532.1% Return on Equity means Ascentage Pharma Grp International generated $-15.32 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ascentage Pharma Grp International:

  • The MRQ is -1,532.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1,532.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,532.1%TTM-1,532.1%0.0%
TTM-1,532.1%YOY-216.1%-1,316.0%
TTM-1,532.1%5Y-411.6%-1,120.5%
5Y-411.6%10Y-257.2%-154.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,532.1%-16.9%-1,515.2%
TTM-1,532.1%-16.1%-1,516.0%
YOY-216.1%-15.1%-201.0%
5Y-411.6%-19.3%-392.3%
10Y-257.2%-20.2%-237.0%

1.2. Operating Efficiency of Ascentage Pharma Grp International.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ascentage Pharma Grp International is operating .

  • Measures how much profit Ascentage Pharma Grp International makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ascentage Pharma Grp International:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2,538.3%+2,538.3%
5Y-2,538.3%10Y-2,626.1%+87.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y-2,538.3%-492.1%-2,046.2%
10Y-2,626.1%-632.4%-1,993.7%
1.2.2. Operating Ratio

Measures how efficient Ascentage Pharma Grp International is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.07 means that the operating costs are $5.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ascentage Pharma Grp International:

  • The MRQ is 5.069. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.069. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.069TTM5.0690.000
TTM5.069YOY5.157-0.089
TTM5.0695Y27.629-22.561
5Y27.62910Y28.040-0.411
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0693.231+1.838
TTM5.0693.310+1.759
YOY5.1573.890+1.267
5Y27.6295.739+21.890
10Y28.0407.876+20.164

1.3. Liquidity of Ascentage Pharma Grp International.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ascentage Pharma Grp International is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.44 means the company has $1.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ascentage Pharma Grp International:

  • The MRQ is 1.439. The company is just able to pay all its short-term debts.
  • The TTM is 1.439. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.439TTM1.4390.000
TTM1.439YOY1.857-0.418
TTM1.4395Y3.385-1.946
5Y3.38510Y4.690-1.305
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4393.890-2.451
TTM1.4394.173-2.734
YOY1.8575.344-3.487
5Y3.3856.126-2.741
10Y4.6906.448-1.758
1.3.2. Quick Ratio

Measures if Ascentage Pharma Grp International is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • A Quick Ratio of 0.16 means the company can pay off $0.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ascentage Pharma Grp International:

  • The MRQ is 0.156. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.156. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.156TTM0.1560.000
TTM0.156YOY1.884-1.728
TTM0.1565Y3.031-2.875
5Y3.03110Y5.309-2.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1563.514-3.358
TTM0.1563.998-3.842
YOY1.8845.380-3.496
5Y3.0316.105-3.074
10Y5.3096.404-1.095

1.4. Solvency of Ascentage Pharma Grp International.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ascentage Pharma Grp International assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ascentage Pharma Grp International to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.97 means that Ascentage Pharma Grp International assets are financed with 97.2% credit (debt) and the remaining percentage (100% - 97.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ascentage Pharma Grp International:

  • The MRQ is 0.972. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.972. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.972TTM0.9720.000
TTM0.972YOY0.856+0.116
TTM0.9725Y0.636+0.336
5Y0.63610Y0.907-0.271
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9720.339+0.633
TTM0.9720.336+0.636
YOY0.8560.271+0.585
5Y0.6360.366+0.270
10Y0.9070.389+0.518
1.4.2. Debt to Equity Ratio

Measures if Ascentage Pharma Grp International is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • A Debt to Equity ratio of 4,021.7% means that company has $40.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ascentage Pharma Grp International:

  • The MRQ is 40.217. The company is unable to pay all its debts with equity. -1
  • The TTM is 40.217. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ40.217TTM40.2170.000
TTM40.217YOY5.926+34.291
TTM40.2175Y9.784+30.432
5Y9.78410Y6.115+3.669
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ40.2170.388+39.829
TTM40.2170.402+39.815
YOY5.9260.335+5.591
5Y9.7840.426+9.358
10Y6.1150.461+5.654

2. Market Valuation of Ascentage Pharma Grp International

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ascentage Pharma Grp International generates.

  • Above 15 is considered overpriced but always compare Ascentage Pharma Grp International to the Biotechnology industry mean.
  • A PE ratio of -7.92 means the investor is paying $-7.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ascentage Pharma Grp International:

  • The EOD is -4.871. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.915. Based on the earnings, the company is expensive. -2
  • The TTM is -7.915. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.871MRQ-7.915+3.044
MRQ-7.915TTM-7.9150.000
TTM-7.915YOY-7.812-0.103
TTM-7.9155Y-9.217+1.302
5Y-9.21710Y-5.761-3.456
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.871-2.264-2.607
MRQ-7.915-2.629-5.286
TTM-7.915-2.680-5.235
YOY-7.812-4.145-3.667
5Y-9.217-6.257-2.960
10Y-5.761-6.254+0.493
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ascentage Pharma Grp International:

  • The EOD is -5.759. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.358. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.358. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.759MRQ-9.358+3.599
MRQ-9.358TTM-9.3580.000
TTM-9.358YOY-7.742-1.616
TTM-9.3585Y-10.245+0.887
5Y-10.24510Y-6.403-3.842
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.759-2.973-2.786
MRQ-9.358-3.333-6.025
TTM-9.358-3.553-5.805
YOY-7.742-5.605-2.137
5Y-10.245-8.376-1.869
10Y-6.403-8.865+2.462
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ascentage Pharma Grp International is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 103.73 means the investor is paying $103.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ascentage Pharma Grp International:

  • The EOD is 63.834. Based on the equity, the company is expensive. -2
  • The MRQ is 103.731. Based on the equity, the company is expensive. -2
  • The TTM is 103.731. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD63.834MRQ103.731-39.896
MRQ103.731TTM103.7310.000
TTM103.731YOY16.878+86.853
TTM103.7315Y29.597+74.134
5Y29.59710Y18.498+11.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD63.8341.896+61.938
MRQ103.7312.115+101.616
TTM103.7312.093+101.638
YOY16.8782.884+13.994
5Y29.5973.542+26.055
10Y18.4983.916+14.582
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ascentage Pharma Grp International compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.260-1.2600%-3.078+144%0.806-256%0.033-3929%
Book Value Per Share--0.2630.2630%1.523-83%2.572-90%1.068-75%
Current Ratio--1.4391.4390%1.857-23%3.385-57%4.690-69%
Debt To Asset Ratio--0.9720.9720%0.856+14%0.636+53%0.907+7%
Debt To Equity Ratio--40.21740.2170%5.926+579%9.784+311%6.115+558%
Dividend Per Share----0%-0%-0%-0%
Eps---3.449-3.4490%-3.290-5%-3.539+3%-2.478-28%
Free Cash Flow Per Share---2.917-2.9170%-3.319+14%-3.069+5%-2.135-27%
Free Cash Flow To Equity Per Share---2.917-2.9170%-1.012-65%-0.175-94%0.305-1058%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---21.807--------
Intrinsic Value_10Y_min---38.477--------
Intrinsic Value_1Y_max---2.885--------
Intrinsic Value_1Y_min---3.530--------
Intrinsic Value_3Y_max---8.135--------
Intrinsic Value_3Y_min---10.951--------
Intrinsic Value_5Y_max---12.742--------
Intrinsic Value_5Y_min---18.693--------
Market Cap4875309465.600-63%7922377881.6007922377881.6000%7458062694.400+6%8688497940.480-9%5430311212.800+46%
Net Profit Margin---4.170-4.1700%-4.210+1%-38.573+825%-34.549+729%
Operating Margin----0%-0%-25.3830%-26.2610%
Operating Ratio--5.0695.0690%5.157-2%27.629-82%28.040-82%
Pb Ratio63.834-63%103.731103.7310%16.878+515%29.597+250%18.498+461%
Pe Ratio-4.871+38%-7.915-7.9150%-7.812-1%-9.217+16%-5.761-27%
Price Per Share16.800-63%27.30027.3000%25.700+6%29.940-9%18.713+46%
Price To Free Cash Flow Ratio-5.759+38%-9.358-9.3580%-7.742-17%-10.245+9%-6.403-32%
Price To Total Gains Ratio-13.338+38%-21.675-21.6750%-8.349-61%-48.381+123%-48.381+123%
Quick Ratio--0.1560.1560%1.884-92%3.031-95%5.309-97%
Return On Assets---0.370-0.3700%-0.312-16%-0.514+39%-0.404+9%
Return On Equity---15.321-15.3210%-2.161-86%-4.116-73%-2.572-83%
Total Gains Per Share---1.260-1.2600%-3.078+144%0.806-256%0.033-3929%
Usd Book Value--9745371.0929745371.0920%56384129.853-83%95232966.133-90%39549074.417-75%
Usd Book Value Change Per Share---0.161-0.1610%-0.393+144%0.103-256%0.004-3929%
Usd Book Value Per Share--0.0340.0340%0.194-83%0.328-90%0.136-75%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.440-0.4400%-0.420-5%-0.452+3%-0.316-28%
Usd Free Cash Flow---108022648.103-108022648.1030%-122917894.267+14%-113642462.210+5%-79044752.943-27%
Usd Free Cash Flow Per Share---0.372-0.3720%-0.424+14%-0.392+5%-0.272-27%
Usd Free Cash Flow To Equity Per Share---0.372-0.3720%-0.129-65%-0.022-94%0.039-1058%
Usd Market Cap622089487.811-63%1010895417.6921010895417.6920%951648799.805+6%1108652337.205-9%692907710.753+46%
Usd Price Per Share2.144-63%3.4833.4830%3.279+6%3.820-9%2.388+46%
Usd Profit---127713728.362-127713728.3620%-121820450.025-5%-131056007.631+3%-91769273.299-28%
Usd Revenue--30627993.77830627993.7780%28934640.349+6%13426734.969+128%8750475.937+250%
Usd Total Gains Per Share---0.161-0.1610%-0.393+144%0.103-256%0.004-3929%
 EOD+3 -5MRQTTM+0 -0YOY+15 -175Y+12 -2110Y+10 -23

3.2. Fundamental Score

Let's check the fundamental score of Ascentage Pharma Grp International based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.871
Price to Book Ratio (EOD)Between0-163.834
Net Profit Margin (MRQ)Greater than0-4.170
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.156
Current Ratio (MRQ)Greater than11.439
Debt to Asset Ratio (MRQ)Less than10.972
Debt to Equity Ratio (MRQ)Less than140.217
Return on Equity (MRQ)Greater than0.15-15.321
Return on Assets (MRQ)Greater than0.05-0.370
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Ascentage Pharma Grp International based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.795
Ma 20Greater thanMa 5018.140
Ma 50Greater thanMa 10021.727
Ma 100Greater thanMa 20023.371
OpenGreater thanClose16.580
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,500,393
Total Liabilities2,429,761
Total Stockholder Equity60,417
 As reported
Total Liabilities 2,429,761
Total Stockholder Equity+ 60,417
Total Assets = 2,500,393

Assets

Total Assets2,500,393
Total Current Assets1,344,178
Long-term Assets1,156,215
Total Current Assets
Cash And Cash Equivalents 1,069,296
Net Receivables 145,893
Inventory 16,167
Total Current Assets  (as reported)1,344,178
Total Current Assets  (calculated)1,231,356
+/- 112,822
Long-term Assets
Property Plant Equipment 957,232
Goodwill 24,694
Intangible Assets 85,446
Long-term Assets  (as reported)1,156,215
Long-term Assets  (calculated)1,067,372
+/- 88,843

Liabilities & Shareholders' Equity

Total Current Liabilities934,173
Long-term Liabilities1,495,588
Total Stockholder Equity60,417
Total Current Liabilities
Short Long Term Debt 606,647
Accounts payable 72,445
Total Current Liabilities  (as reported)934,173
Total Current Liabilities  (calculated)679,092
+/- 255,081
Long-term Liabilities
Long term Debt 1,166,267
Capital Lease Obligations Min Short Term Debt22,681
Long-term Liabilities  (as reported)1,495,588
Long-term Liabilities  (calculated)1,188,948
+/- 306,640
Total Stockholder Equity
Total Stockholder Equity (as reported)60,417
Total Stockholder Equity (calculated)0
+/- 60,417
Other
Capital Stock197
Common Stock Shares Outstanding 290,197
Net Debt 703,618
Net Invested Capital 1,833,331
Net Working Capital 410,005
Property Plant and Equipment Gross 1,108,063



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
593,341
581,664
1,229,376
1,205,050
1,731,039
2,940,060
2,830,261
2,500,393
2,500,3932,830,2612,940,0601,731,0391,205,0501,229,376581,664593,341
   > Total Current Assets 
463,699
414,713
990,219
909,105
1,079,044
1,885,280
1,636,488
1,344,178
1,344,1781,636,4881,885,2801,079,044909,105990,219414,713463,699
       Cash And Cash Equivalents 
294,529
14,821
957,088
878,510
1,024,400
1,743,821
1,345,639
1,069,296
1,069,2961,345,6391,743,8211,024,400878,510957,08814,821294,529
       Short-term Investments 
157,390
384,168
14,399
0
0
0
130,000
0
0130,00000014,399384,168157,390
       Net Receivables 
8,308
7,853
5,253
2,526
13,368
53,968
54,356
145,893
145,89354,35653,96813,3682,5265,2537,8538,308
       Other Current Assets 
78
164
6,421
26,648
54,644
83,561
28,506
0
028,50683,56154,64426,6486,42116478
   > Long-term Assets 
129,642
166,951
239,157
295,945
651,995
1,054,780
1,193,773
1,156,215
1,156,2151,193,7731,054,780651,995295,945239,157166,951129,642
       Property Plant Equipment 
4,513
25,330
67,240
110,224
447,878
824,444
650,025
957,232
957,232650,025824,444447,878110,22467,24025,3304,513
       Goodwill 
24,694
24,694
24,694
24,694
24,694
24,694
24,694
24,694
24,69424,69424,69424,69424,69424,69424,69424,694
       Long Term Investments 
12,551
30,328
59,518
0
0
0
0
0
0000059,51830,32812,551
       Intangible Assets 
87,129
80,709
75,280
72,192
66,405
60,411
84,304
85,446
85,44684,30460,41166,40572,19275,28080,70987,129
       Other Assets 
755
5,890
12,425
24,581
52,121
97,462
62,097
0
062,09797,46252,12124,58112,4255,890755
> Total Liabilities 
607,947
713,461
2,240,962
314,575
884,418
1,705,323
2,421,603
2,429,761
2,429,7612,421,6031,705,323884,418314,5752,240,962713,461607,947
   > Total Current Liabilities 
77,618
79,535
105,269
202,062
276,148
361,109
881,152
934,173
934,173881,152361,109276,148202,062105,26979,53577,618
       Short-term Debt 
157,390
384,168
14,399
85,000
44,750
0
139,900
0
0139,900044,75085,00014,399384,168157,390
       Short Long Term Debt 
0
0
0
85,000
44,750
39,800
510,305
606,647
606,647510,30539,80044,75085,000000
       Accounts payable 
156
3,822
5,081
13,084
23,361
70,861
95,559
72,445
72,44595,55970,86123,36113,0845,0813,822156
       Other Current Liabilities 
56,199
44,894
14,339
5,027
141,646
165,478
0
0
00165,478141,6465,02714,33944,89456,199
   > Long-term Liabilities 
530,329
633,926
2,135,693
112,513
608,270
1,344,214
1,540,451
1,495,588
1,495,5881,540,4511,344,214608,270112,5132,135,693633,926530,329
       Long term Debt Total 
472
2,879
2,080,068
9,211
479,134
1,034,839
1,274,344
0
01,274,3441,034,839479,1349,2112,080,0682,879472
       Other Liabilities 
529,857
631,047
55,625
103,302
129,136
309,375
0
0
00309,375129,136103,30255,625631,047529,857
> Total Stockholder Equity
-14,606
-131,797
-1,011,586
890,475
846,621
1,234,737
408,658
60,417
60,417408,6581,234,737846,621890,475-1,011,586-131,797-14,606
   Common Stock
0
0
63
142
154
178
180
0
01801781541426300
   Retained Earnings -5,365,122-4,798,720-3,556,561-2,774,137-2,096,531-615,817-270,510-151,996
   Capital Surplus 
0
0
43,698
3,454,371
4,130,420
5,342,072
5,393,029
0
05,393,0295,342,0724,130,4203,454,37143,69800
   Treasury Stock00-3-4-4-400
   Other Stockholders Equity 
137,390
138,713
-439,526
-467,503
-509,812
-550,949
-159,279
0
0-159,279-550,949-509,812-467,503-439,526138,713137,390



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue221,984
Cost of Revenue-30,543
Gross Profit191,441191,441
 
Operating Income (+$)
Gross Profit191,441
Operating Expense-1,094,620
Operating Income-872,636-903,179
 
Operating Expense (+$)
Research Development706,972
Selling General Administrative376,463
Selling And Marketing Expenses-
Operating Expense1,094,6201,083,435
 
Net Interest Income (+$)
Interest Income32,409
Interest Expense-96,057
Other Finance Cost-0
Net Interest Income-63,648
 
Pretax Income (+$)
Operating Income-872,636
Net Interest Income-63,648
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-932,862-872,636
EBIT - interestExpense = -96,057
-925,637
-829,580
Interest Expense96,057
Earnings Before Interest and Taxes (EBIT)--836,805
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-932,862
Tax Provision--7,150
Net Income From Continuing Ops-925,712-925,712
Net Income-925,637
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-63,648
 

Technical Analysis of Ascentage Pharma Grp International
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ascentage Pharma Grp International. The general trend of Ascentage Pharma Grp International is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ascentage Pharma Grp International's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ascentage Pharma Grp International.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 18.54 < 19.30 < 20.75.

The bearish price targets are: 15.60 > 11.24 > 11.16.

Tweet this
Ascentage Pharma Grp International Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ascentage Pharma Grp International. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ascentage Pharma Grp International Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ascentage Pharma Grp International. The current macd is -1.60391702.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ascentage Pharma Grp International price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ascentage Pharma Grp International. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ascentage Pharma Grp International price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ascentage Pharma Grp International Daily Moving Average Convergence/Divergence (MACD) ChartAscentage Pharma Grp International Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ascentage Pharma Grp International. The current adx is 36.27.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ascentage Pharma Grp International shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Ascentage Pharma Grp International Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ascentage Pharma Grp International. The current sar is 15.42.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ascentage Pharma Grp International Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ascentage Pharma Grp International. The current rsi is 34.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Ascentage Pharma Grp International Daily Relative Strength Index (RSI) ChartAscentage Pharma Grp International Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ascentage Pharma Grp International. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ascentage Pharma Grp International price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ascentage Pharma Grp International Daily Stochastic Oscillator ChartAscentage Pharma Grp International Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ascentage Pharma Grp International. The current cci is -59.77114317.

Ascentage Pharma Grp International Daily Commodity Channel Index (CCI) ChartAscentage Pharma Grp International Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ascentage Pharma Grp International. The current cmo is -25.51937288.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ascentage Pharma Grp International Daily Chande Momentum Oscillator (CMO) ChartAscentage Pharma Grp International Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ascentage Pharma Grp International. The current willr is -54.30463576.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ascentage Pharma Grp International is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ascentage Pharma Grp International Daily Williams %R ChartAscentage Pharma Grp International Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ascentage Pharma Grp International.

Ascentage Pharma Grp International Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ascentage Pharma Grp International. The current atr is 1.01120498.

Ascentage Pharma Grp International Daily Average True Range (ATR) ChartAscentage Pharma Grp International Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ascentage Pharma Grp International. The current obv is -14,875,168.

Ascentage Pharma Grp International Daily On-Balance Volume (OBV) ChartAscentage Pharma Grp International Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ascentage Pharma Grp International. The current mfi is 40.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ascentage Pharma Grp International Daily Money Flow Index (MFI) ChartAscentage Pharma Grp International Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ascentage Pharma Grp International.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Ascentage Pharma Grp International Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ascentage Pharma Grp International based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.795
Ma 20Greater thanMa 5018.140
Ma 50Greater thanMa 10021.727
Ma 100Greater thanMa 20023.371
OpenGreater thanClose16.580
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ascentage Pharma Grp International with someone you think should read this too:
  • Are you bullish or bearish on Ascentage Pharma Grp International? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ascentage Pharma Grp International? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ascentage Pharma Grp International

I send you an email if I find something interesting about Ascentage Pharma Grp International.


Comments

How you think about this?

Leave a comment

Stay informed about Ascentage Pharma Grp International.

Receive notifications about Ascentage Pharma Grp International in your mailbox!